Thursday November 26, 2020

Brandon in new €3m development joint venture

Serial entrepreneur Gerry Brandon has signed a €3 million joint venture agreement with a view to developing biodegradable human implants and bringing them to market.

18th May, 2013

Serial entrepreneur Gerry Brandon has signed a €3 million joint venture agreement with a view to developing biodegradable human implants and bringing them to market.

The consortium is made up of three companies: Brandon's Cellulac Ltd, clinical research organisation Venn Life Sciences and Mayo-based medical device company Biopharmed West.

A new arm of Venn Life Sciences with a focus on co-development opportunities, InnoVenn, is the division involved in the venture.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 10 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 5 years ago